Search

Search Constraints

You searched for: Author/Creator Neumann, Sebastian

Search Results

1. Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines. (4th March 2017)